BerganKDV Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$900 Sell
7
-15
-68% -$1.81K ﹤0.01% 767
2023
Q1
$2.56K Hold
22
﹤0.01% 798
2022
Q4
$2.49K Sell
22
-12
-35% -$1.32K ﹤0.01% 776
2022
Q3
$3K Sell
34
-230
-87% -$19.5K ﹤0.01% 748
2022
Q2
$20K Buy
264
+8
+3% +$730 ﹤0.01% 495
2022
Q1
$33K Hold
256
﹤0.01% 444
2021
Q4
$34K Hold
256
﹤0.01% 474
2021
Q3
$35K Hold
256
﹤0.01% 446
2021
Q2
$27K Hold
256
﹤0.01% 478
2021
Q1
$23K Hold
256
﹤0.01% 463
2020
Q4
$24K Buy
256
+228
+814% +$20.4K ﹤0.01% 443
2020
Q3
$3K Hold
28
﹤0.01% 638
2020
Q2
$3K Buy
+28
New +$2.5K ﹤0.01% 694

Other funds holding DXCM

BerganKDV Wealth Management's DXCM Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its DexCom (DXCM) stake by 68% in Q2 2023, selling an estimated $1.81K and leaving 7 shares worth $900. The position accounts for ﹤0.01% of the portfolio, ranked #767.

BerganKDV Wealth Management first reported a position in DXCM in Q2 2020 and has held it in 13 quarters since. The position peaked at $35K in Q3 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • BerganKDV Wealth Management held 7 shares of DexCom worth $900 as of Q2 2023.
  • BerganKDV Wealth Management sold 15 DexCom shares in Q2 2023, an estimated $1.81K.
  • DexCom made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #767 holding.
  • BerganKDV Wealth Management first reported a position in DexCom in Q2 2020 and has held it in 13 quarters since.
  • BerganKDV Wealth Management's DexCom position peaked at $35K in Q3 2021.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.